iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication
Go back to iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication| (NASDAQ: IMDX) | Delayed: 4.00 +0.05 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.95 | 52 Week High | $ | |||
| Open | $3.90 | 52 Week Low | $ | |||
| Day High | $4.10 | P/E | N/A | |||
| Day Low | $3.77 | EPS | $ | |||
| Volume | 317,924 | |||||
